Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$32,804,413
+$1,071,429 QoQ
Shares Held
27,350
-20.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#683
of 4,605 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $150,710,322 across 7 Drug Manufacturers - General names. LLY ranks #3 (21.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
311,108 | $39,977,378 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
294,685 | $37,230,502 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
27,350 | $32,804,413 | |
| 4 | ABBV |
AbbVie Inc.
|
118,057 | $29,707,863 | |
| 5 | PFE |
Pfizer Inc
|
221,058 | $5,323,076 | |
| 6 | JNJ |
Johnson & Johnson
|
20,023 | $5,085,241 | |
| 7 | BIIB |
Biogen Inc.
|
2,693 | $581,849 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,804,413 | 27,350 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $31,732,984 | 34,501 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $25,190,445 | 33,015 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $22,298,455 | 28,605 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $24,699,664 | 29,906 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $21,088,724 | 27,317 | Shares | Sole | 2025-02-11 | |
| 2024-06-30 | $25,462,001 | 28,123 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,420,858 | 22,393 | Shares | Sole | 2025-07-09 | |
| 2023-12-31 | $12,813,747 | 21,982 | Shares | Sole | 2025-07-09 | |
| 2023-09-30 | $13,654,918 | 25,422 | Shares | Sole | 2025-07-09 | |
| 2023-06-30 | $19,045,277 | 40,610 | Shares | Sole | 2025-07-09 | |
| 2023-03-31 | $10,161,454 | 29,589 | Shares | Sole | 2025-07-09 | |
| 2022-12-31 | $13,119,754 | 35,862 | Shares | Sole | 2025-07-09 | |
| 2022-09-30 | $9,590,561 | 29,660 | Shares | Sole | 2025-07-09 | |
| 2022-06-30 | $9,414,018 | 29,035 | Shares | Sole | 2025-07-09 | |
| 2022-03-31 | $8,541,844 | 29,828 | Shares | Sole | 2025-07-09 | |
| 2021-12-31 | $10,171,525 | 36,824 | Shares | Sole | 2025-07-09 | |
| 2021-09-30 | $9,057,853 | 39,203 | Shares | Sole | 2025-07-09 | |
| 2021-06-30 | $11,768,867 | 51,276 | Shares | Sole | 2025-07-09 | |
| 2021-03-31 | $9,900,525 | 52,995 | Shares | Sole | 2025-07-09 | |
| 2020-12-31 | $9,650,894 | 57,160 | Shares | Sole | 2025-07-08 | |
| 2020-09-30 | $7,325,065 | 49,487 | Shares | Sole | 2025-07-08 | |
| 2020-06-30 | $7,712,027 | 46,973 | Shares | Sole | 2025-07-08 | |
| 2020-03-31 | $8,914,702 | 64,264 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||